Summary
Support the advanced development of therapeutic products for Marburg Virus and other NIAID Category A, B, and C Priority Pathogens or emerging infectious diseases.
Development of Therapeutic Products for Marburg Virus
US
National Institutes of Health
grant
open
#nih-75N93021C00021-P00011-9999-1
What they want
Research and development activities to progress candidate therapeutic products through the product development pathway, including preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
Deliverables
- Preclinical development activities
- IND enabling development activities
- Chemistry optimization/development
- GMP manufacturing
- Clinical safety and efficacy assessment
Technical requirements
- Candidate therapeutic product for NIAID Category A, B, and C Priority Pathogens or emerging infectious diseases
